PATENT CLAIM ANALYSIS

Application Number: 15924886
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "274000"]

Abstract:
The present disclosure provides for methods of treating cancer in a subject. In certain embodiments, the method comprises administering a therapeutically effective amount of an inhibitor of fatty acid synthase, or a pharmaceutically acceptable salt or prodrug thereof.

Claim (Index 1):
A compound of Formula (I): or a pharmaceutically acceptable salt thereof, wherein each of R 1 , R 2  and R 3  is independently selected from hydrogen, alkyl, alkenyl, alkynyl, aromatic, heterocyclic, halogen, hydroxyl, carbonyl, aldehyde, carboxylic acid, ester, ether, amide, amino, nitro, nitrile, thiol, and sulfonic acid; wherein each of R 4  and R 5  is independently selected from carbonyl or hydroxyl; wherein X is independently selected from alkyl, alkenyl, alkynyl, amine, ether, carbonyl, ester, carboxamide, sulfide, sulfinyl, and sulfonyl; and wherein Y is between 2 and 20.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 90.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10866141', '12390753', '13579967', '15346443', '11622229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7674300202231843
- 35 USC 102 Novelty (BERT): 0.5004569879537375
- Combined Prediction Score: 0.7407327169962397
- Mean Citation Score: 228.401798
- Max Citation Score: 235.44443
- Similarity Product: 164.0989079599297

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test